Subject: Temporary importation of Hartmann s (Compound Sodium Lactate) 1L from Spain to address manufacturing disruption in UK

Size: px
Start display at page:

Download "Subject: Temporary importation of Hartmann s (Compound Sodium Lactate) 1L from Spain to address manufacturing disruption in UK"

Transcription

1 5 th September 2018 Subject: Temporary importation of Hartmann s (Compound Sodium Lactate) 1L from Spain to address manufacturing disruption in UK Dear Customer, In order to address shortages of critical drug products following a continued disruption in the supply of our IV Solutions, Baxter is coordinating with the MHRA to increase the availability of IV fluid in the UK, by temporarily importing product from its manufacturing facility in Spain. What you need to know and do This product is classified as licensed and is covered by a Batch Specific Variation approved by the MHRA. The imported product is identical to product you will have already been using, only the label copy is different. The labelling is in both English and French language. The bags are fully compatible with Baxter IV sets marketed in the UK. As with all IV solutions, it is important to check for leaks prior to use by squeezing the inner bag firmly. If leaks are found, discard solution as sterility may be impaired. Additionally, check to see that solution is clear and free of foreign matter. Discard the solution if solution is not clear. Do not remove from overwrap until ready for use. Do not reconnect partially used bags. The new code must be set up in ordering systems to facilitate ordering. More information is provided on page 2. Report all Adverse Events and Quality Defects as per your normal procedure. Further details are provided on page 2. Details of the product Product Name Size Product Code Pack Factor Batch Numbers Ringer Lactate Solution (Compound Sodium Lactate Hartmann s Solution) in Viaflo 1000 ml XE per box The batches involved are listed in Attachment 2 Effective immediately during this temporary period, Baxter will offer this product to an identified group of NHS Hospitals in England and Wales as an alternative to its UK Viaflo equivalent product FKE2324 Hartmann s (Compound Sodium Lactate) 1000ml. There are some key differences in the labeling between the UK marketed product and the imported product. Please see additional information at the end of this letter for: Attachment 1: Comparison Table of UK product vs imported product Attachment 2: FAQ document for customer use Baxter Healthcare Ltd Wallingford Road / Compton / Newbury / Berkshire / RG20 7QW / Great Britain T F Registered Office: Caxton Way / Thetford / Norfolk / IP24 3SE Registered in England No

2 Ordering In order to enable ease of ordering and invoicing, it is important that customers please set up the new code in their ordering systems. The new code will appear on purchase orders dated from 10th September onwards, when the imported stock will be ready to ship. Product Name Size Product Code Ringer Lactate Solution (Compound Sodium Lactate Hartmann s Solution) in Viaflo 1000 ml Pack Factor GTIN /EAN Code for Carton GTIN /EAN Code for Unit XE per box To place an order, please contact Baxter Customer Service on Reporting Adverse Events and Quality Defects Please report suspected adverse drug reactions (ADRs) to the MHRA through the Yellow Card Scheme. It is easiest and quickest to report ADRs online via the Yellow Cards website - Please ensure that any reports include details of the product code XE2324. Please report: all suspected ADRs that are serious or result in harm. Serious reactions are those that are fatal, life-threatening, disabling or incapacitating, those that cause a congenital abnormality or result in hospitalisation, and those that are considered medically significant for any other reason. When reporting please provide as much information as possible, including information about medical history, any concomitant medication, onset, treatment dates. Adverse Events relating to Baxter products can also be reported direct to Baxter Pharmacovigilance on , or by to vigilanceuk@baxter.com. Any drug product quality complaints (including suspected defective medicines) relating to Baxter products can be reported directly to the Baxter Country Quality Assurance Team on , or by to UK_SHS_QA_Complaints@baxter.com. Alternatively, please report directly to your Baxter Account Manager who will take the details and forward to the Baxter Country Quality Assurance Team. A copy of the UK approved leaflet is available via the Baxter Product Catalogue, within the Clinical Data section for Product Code FKE2324, or by calling the Marketing Authorization Holder on If you have any questions about the information contained in this letter, or the use of the imported product, please contact your Baxter Account Manager or Baxter Medical Information on Yours faithfully Victoria Franklin Product Manager UK & Ireland Baxter Fluid Systems

3 Attachment 1 Comparison Table of UK product vs Imported product UK Standard Product Product code FKE2324 Imported Product Product code XE2324 Bag label Carton label Product Name Licence Status Active Compound Sodium Lactate Solution for Infusion BP Synonyms: Ringer Lactate; Hartmann s Solution BP UK registered product under Marketing Authorisation PL00116/0330 Sodium 131 mmol/l, potassium 5 mmol/l, Calcium 2 mmol/l, chloride 111 mmol/l, lactate 29 mmol/l Ringer Lactate Solution (Compound Sodium Lactate - Hartmann s Solution) BP Covered by PL00116/0330 by Batch Specific Variation although the licence number is not on the labelling. Batch numbers 18H16E9C, 18H18E9P, 18H27E9M, 18H29E9J. Other batches may be added Sodium 131 mmol/l, potassium 5 mmol/l, Calcium 2 mmol/l, chloride 111 mmol/l, lactate 29 mmol/l Excipients Water for injections, EP Water for injections, EP Additional ph ph Information Osmolarity 278 mosmol/l Osmolarity 278 mosmol/l Labelled Storage temp. Container type No special precautions for storage Store below 25 C Both products may be stored at ambient temperatures. Product can be stored in the over pouch up to 40 C for a period of 14 weeks. See also FAQs Viaflo (polyolefin/polyamide co-extruded plastic) Supplied in an overwrap. Twist off port protector (white colour) Viaflo (polyolefin/polyamide co-extruded plastic) Supplied in an overwrap. Twist off port protector (white colour) Administration port closure Baxter Customer Services: Tel: Baxter Medical Information: v1.0 05/09/18

4 Bag Labels Carton Labels Baxter Healthcare Ltd Wallingford Road / Compton / Newbury / Berkshire / RG20 7QW / Great Britain T F Registered Office: Caxton Way / Thetford / Norfolk / IP24 3SE Registered in England No v1.0 05/09/18

5 Attachment 2 Compound Sodium Lactate Solution for Infusion BP (Synonyms: Ringer s lactate; Hartmann s solution) Frequently Asked Questions IMPORTANT: Due to the risk of coagulation precipitated by its calcium content, Compound Sodium Lactate solution must not be added to or administered simultaneously through the same tubing with citrate anticoagulated/preserved blood. Please refer to the Summary of Product Characteristics for full product details. This can be found at Is the replacement product licensed? Yes. The product is covered by the UK product license issued by the Medicines and Healthcare products Regulatory Authority (MHRA) under a batch specific variation to allow for the differences in the labelling from the normal UK product. The product is the same as UK approved product in all other respects. The batches approved by the MHRA are listed below. Note that this list will be updated as and when new batches become available. Batch Numbers Approved by the MHRA as of 5 th September H16E9C 18H18E9P 18H27E9M 18H29E9J What is the replacement product? Compound Sodium Lactate solution has several synonyms. These include Ringer s Lactate and Hartmann s solution. The manufacturing, the material of the bag and the electrolyte composition is the same as the UK approved product. The only difference is the label on the bag. The replacement product is intended for humanitarian aid use. What are the differences between the products? The only difference is the labelling on the primary bag and carton. All other aspects are the same as the Viaflo bags currently in use. Storage, handling and use of these bags of Hartmann s solution is the same as your current practice. The labelling for the imported product has a storage temperature of below 25 C. Solutions in the 1000ml Viaflo container can be stored in their over pouch to temperatures not exceeding 40 C for a period of 14 weeks but should be identified as having been stored at a higher temperature and should not be subsequently warmed. Are the imported bags of Hartmann s solution latex free? Baxter can confirm we do not use natural rubber latex components in the manufacture of products in Viaflo containers. Are the imported bags of Hartmann s solution DEHP free? Yes. The Viaflo bags do not contain di-ethlyhexyl phthalate (DEHP). P a g e 1 2 v1.0 05/09/18

6 Is the surface of the primary bag inside the overwrap sterile? Baxter Viaflex bags are sealed within their over pouch and then terminally sterilised using steam. Therefore, both the primary container and it s over pouch are considered sterilised. However, we cannot guarantee that the outer surface of the primary container will still be sterile when you open the over pouch as the over pouch may have been compromised during transport, storage and handling. Care should be taken when handling the products to minimise the risk of damage and the potential for contamination of the surface of the inner bag. Can I have a certificate of analysis? Yes. Please your request to servicecs@baxter.com, including details of the batch number(s) you require the certificate(s) for. When will the next delivery arrive? For details about specific orders and deliveries please refer to the local Commercial Business Manager or Customer Services on Are the Medicines and Healthcare products Regulatory Agency (MHRA) and Department of Health & Social Care (DHSC) aware? Baxter is working hard with the MHRA and the DHSC to ensure IV fluids continue to be supplied. The replacement product is covered by the UK product licence issued by the MHRA under a batch specific variation to allow for the differences in the labelling from the normal UK product. The product is the same as UK approved product in all other respects. Where can I find more information? For additional details regarding the use of Compound Sodium Lactate Solution for Infusion (Hartmann s solution) please contact Baxter Medical Information. Baxter Medical Information: For details about supply please contact Baxter Customer service or your local account manager. Baxter Customer Services: Tel: Baxter Healthcare Ltd Wallingford Road / Compton / Newbury / Berkshire / RG20 7QW / Great Britain T F Registered Office: Caxton Way / Thetford / Norfolk / IP24 3SE Registered in England No P a g e 2 2 v1.0 05/09/18

Sodium Chloride 0.9% w/v Intravenous Infusion BP

Sodium Chloride 0.9% w/v Intravenous Infusion BP PACKAGE LEAFLET: INFORMATION FOR THE USER Sodium Chloride 0.9% w/v Intravenous Infusion BP Active substance: sodium chloride Read all of this leaflet carefully before you are given this medicine because

More information

*Newly Released Vials consist of lot numbers: 183aG117, 183aG217, 184aG117, 184aG aG117 and 185aG217

*Newly Released Vials consist of lot numbers: 183aG117, 183aG217, 184aG117, 184aG aG117 and 185aG217 *Newly Released Vials consist of lot numbers: 183aG117, 183aG217, 184aG117, 184aG217 185aG117 and 185aG217 SPECIAL HANDLING INSTRUCTIONS VIALS of ERWINASE FROM BATCHes 183a, 184a And 185a* should be used

More information

D R U G A L E R T CLASS 4 MEDICINES DEFECT INFORMATION Caution in Use Distribute to Pharmacy, Hospital, GP, Ward and Clinic Level

D R U G A L E R T CLASS 4 MEDICINES DEFECT INFORMATION Caution in Use Distribute to Pharmacy, Hospital, GP, Ward and Clinic Level D R U G A L E R T CLASS 4 MEDICINES DEFECT INFORMATION Caution in Use Distribute to Pharmacy, Hospital, GP, Ward and Clinic Level Shire BUCCOLAM 2.5 mg, 5 mg, 7.5 mg and 10 mg Oromuscosal Solution Pre-filled

More information

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium Package leaflet: Information for the patient Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion Active substance: Heparin Sodium Read all of this leaflet carefully before you are given

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Synthamin 14, 8.5% Amino Acid Intravenous Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION L-Leucine Ph. Eur 0.620% w/v L-Isoleucine

More information

Package leaflet: Information for the user. multibic potassium-free solution for haemodialysis/haemofiltration

Package leaflet: Information for the user. multibic potassium-free solution for haemodialysis/haemofiltration Package leaflet: Information for the user multibic potassium-free solution for haemodialysis/haemofiltration Read all of this leaflet carefully before you start using this medicine because it contains

More information

Sodium Chloride 0.9%w/v Intravenous Infusion BP

Sodium Chloride 0.9%w/v Intravenous Infusion BP PACKAGE LEAFLET: INFORMATION FOR THE USER Sodium Chloride 0.9%w/v Intravenous Infusion BP Active substance: sodium chloride Read all of this leaflet carefully before you are given this medicine because

More information

Sodium Chloride Injection, USP in VIAFLO Plastic Container

Sodium Chloride Injection, USP in VIAFLO Plastic Container Sodium Chloride Injection, USP in VIAFLO Plastic Container DESCRIPTION Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers

More information

2. What you need to know before you use Compound Sodium Lactate

2. What you need to know before you use Compound Sodium Lactate Package leaflet: Information for the user Compound Sodium Lactate Intravenous Infusion BP, Ecobag (Hartmann s Solution) Read all of this leaflet carefully before you start using this medicine because it

More information

Please see the attached drug alert for onward transmission as below.

Please see the attached drug alert for onward transmission as below. Chief Medical Officer Directorate Pharmacy and Medicines Division T: 0131-244 2528 E: irene.fazakerley@gov.scot IMMEDIATE MESSAGE TO: 1. Directors of Pharmacy 2. Medical Directors NHS Boards 18 April 2018

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Mannitol 15% w/v Solution for Infusion mannitol

PACKAGE LEAFLET: INFORMATION FOR THE USER. Mannitol 15% w/v Solution for Infusion mannitol PACKAGE LEAFLET: INFORMATION FOR THE USER Mannitol 15% w/v Solution for Infusion mannitol Read all of this leaflet carefully before you are given this medicine because it contains important information

More information

Hartmann s Solution. For Infusion

Hartmann s Solution. For Infusion 0xxxxx1_00_HartmannsSolution_IE_BP 07.02.2017 13:15 Seite 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Hartmann s Solution For Infusion Read all of this leaflet carefully before you start using this medicine

More information

Potassium chloride: Calcium chloride dihydrate:

Potassium chloride: Calcium chloride dihydrate: 1. NAME OF THE MEDICINAL PRODUCT Ringer s Solution for Infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium chloride: Potassium chloride: Calcium chloride dihydrate: 8.60 g/l 0.30 g/l 0.33 g/l

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Lartruvo 10 mg/ml concentrate for solution for infusion olaratumab This medicine is subject to additional monitoring. This will allow quick identification of new

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Ringer s Solution for Infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER Ringer s Solution for Infusion PACKAGE LEAFLET: INFORMATION FOR THE USER Ringer s Solution for Infusion Active substances: sodium chloride, potassium chloride and calcium chloride dihydrate Read all of this leaflet carefully before

More information

0.45% Sodium Chloride Injection, USP

0.45% Sodium Chloride Injection, USP PRESCRIBING INFORMATION 0.45% Sodium Chloride Injection, USP IV Fluid and Electrolyte Replenisher Baxter Corporation Mississauga, Ontario L5N 0C2 Canada Date of Revision: November 22, 2013 Submission Control

More information

3% Sorbitol Urologic Irrigating Solution in UROMATIC Plastic Container

3% Sorbitol Urologic Irrigating Solution in UROMATIC Plastic Container 3% Sorbitol Urologic Irrigating Solution in UROMATIC Plastic Container Description 3% Sorbitol Urologic Irrigating Solution is a sterile, nonpyrogenic, nonhemolytic, electrically nonconductive solution

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PRIMENE 10% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each litre of the infusion solution contains: L-Isoleucine L-Leucine L-Valine

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP

SUMMARY OF PRODUCT CHARACTERISTICS. Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium Chloride:

More information

Sodium Chloride Injection, USP in VIAFLEX Plastic Container

Sodium Chloride Injection, USP in VIAFLEX Plastic Container Sodium Chloride Injection, USP in VIAFLEX Plastic Container DESCRIPTION Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers

More information

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it

More information

Package leaflet: information for the user. Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration

Package leaflet: information for the user. Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration Package leaflet: information for the user Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration Calcium chloride dihydrate/ magnesium chloride hexahydrate/ glucose monohydrate/ lactic

More information

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride Package leaflet: Information for the user Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride Read all of this leaflet carefully before using this medicine because it

More information

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab Package leaflet: Information for the user Portrazza 800 mg concentrate for solution for infusion necitumumab This medicine is subject to additional monitoring. This will allow quick identification of new

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Parsabiv 2.5 mg solution for injection Parsabiv 5 mg solution for injection Parsabiv 10 mg solution for injection etelcalcetide This medicine is subject to

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) PACKAGE LEAFLET: INFORMATION FOR THE USER Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) Read all of this leaflet carefully before you start using this medicine

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Aimovig 70 mg solution for injection in pre-filled pen erenumab This medicine is subject to additional monitoring. This will allow quick identification of new

More information

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil Read all of this leaflet carefully before you start using this medicine because

More information

pí=^åçêéïûë=eçìëé= oéöéåí=oç~ç= bçáåäìêöü=ben=pad= = = IMMEDIATE MESSAGE TO:

pí=^åçêéïûë=eçìëé= oéöéåí=oç~ç= bçáåäìêöü=ben=pad= = = IMMEDIATE MESSAGE TO: abcdefghijklm eé~äíüaéé~êíãéåí pí^åçêéïûëeçìëé oéöéåíoç~ç bçáåäìêöübenpad IMMEDIATE MESSAGE TO: qéäééüçåéwmnpnjoqqjorou c~ñwmnpnjoqqoptr ÉJã~áäWáêÉåÉKÑçëíÉê]ëÅçíä~åÇKÖëáKÖçîKìâ 1. Specialists in Pharmaceutical

More information

Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride

Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride Package leaflet: Information for the user Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride Read all of this leaflet carefully before

More information

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the user. Carmellose sodium Package leaflet: Information for the user CELLUVISC 0.5% w/v, eye drops, solution, unit dose Carmellose sodium Read all of this leaflet carefully before you start using this medicine because it contains

More information

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin Package leaflet: Information for the patient Verkazia 1 mg/ml eye drops emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate Package leaflet: Information for the patient Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate Read all of this leaflet carefully before you are given this medicine because

More information

Quality, Safety and Sourcing in Unlicensed Medicines

Quality, Safety and Sourcing in Unlicensed Medicines Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?

More information

WHOPAR part 5 Suppliers submission of the SRA approved text

WHOPAR part 5 Suppliers submission of the SRA approved text PARTICULARS TO APPEAR ON THE OUTER PACKAGING ΒΟΧ x 1 plastic ampoule x 2ml [4ml] 1. NAME OF THE MEDICINAL PRODUCT Ζophralen Ondansetron 2. STATEMENT OF ACTIVE SUBSTANCE(S) Each 2ml [4ml] plastic ampoule

More information

IMPORTANT DRUG INFORMATION

IMPORTANT DRUG INFORMATION IMPORTANT DRUG INFORMATION 2 nd January 2019 Subject: ERWINAZE Batch 191K Notice of *New* Special Handling Instructions Use a 0.2-micron, low protein binding, in-line filter for IV administration of ERWINAZE

More information

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control Unofficial translation /Ministry of Social Affairs and Health No. 548/2008 Government Decree on Narcotics Control Issued in Helsinki on 28 August 2008 Section 1 Scope of application This Decree lays down

More information

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac Package Leaflet: Information for the user NEVANAC 3 mg/ml eye drops, suspension nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite Package leaflet: Information for the patient Selenium 10 micrograms/ml concentrate for solution for infusion Sodium selenite Read all of this leaflet carefully before you start using this medicine because

More information

Autologous plasma eye drops. Patient information

Autologous plasma eye drops. Patient information Autologous plasma eye drops Patient information Autologous plasma eye drops are made from the patient s own blood and are used to help treat their corneal surface defects and diseases. This leaflet gives

More information

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin Package leaflet: Information for the patient NEGABAN 1g, powder for solution for injection or infusion Temocillin Read all of this leaflet carefully before you start using this medicine because it contains

More information

Reference ID:

Reference ID: HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRISMASOL and PHOXILLUM safely and effectively. See full prescribing information for PRISMASOL and

More information

The Orabloc cartridges. > 50 years of Pharmaceutical & Life Science Services

The Orabloc cartridges. > 50 years of Pharmaceutical & Life Science Services The Orabloc cartridges Orabloc cartridge components Aluminum Cap Neutral USP Type I Glass Neck Rubber plunger Sliding Plunger For Dose Administration Special Rubber Cap Seal Orabloc cartridge components

More information

0.45% Sodium Chloride Injection, USP

0.45% Sodium Chloride Injection, USP PRESCRIBING INFORMATION 0.45% Sodium Chloride Injection, USP Solution for Infusion Intravenous Fluid and Electrolyte Replenisher Baxter Corporation Mississauga, Ontario L5N 0C2 Canada Date of Revision:

More information

Package leaflet: Information for the patient. Ruconest 2100 U powder and solvent for solution for injection Conestat alfa

Package leaflet: Information for the patient. Ruconest 2100 U powder and solvent for solution for injection Conestat alfa Package leaflet: Information for the patient Ruconest 2100 U powder and solvent for solution for injection Conestat alfa Read all of this leaflet carefully before you start using this medicine because

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Sodium Chloride Infusion BP 0.9%, as Steriflex No. 1 or freeflex 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Steriflex No. 1 has the

More information

1. What Faslodex is and what it is used for

1. What Faslodex is and what it is used for Package leaflet: Information for the user Faslodex 250 mg solution for injection Fulvestrant Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

*Sections or subsections omitted from the full prescribing information are not 6 ADVERSE REACTIONS

*Sections or subsections omitted from the full prescribing information are not 6 ADVERSE REACTIONS HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRISMASOL and PHOXILLUM safely and effectively. See full prescribing information for PRISMASOL and

More information

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses

More information

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex Package leaflet: Information for the user Bridion 100 mg/ml solution for injection sugammadex Read all of this leaflet carefully before you are given this medicine because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin PACKAGE LEAFLET: INFORMATION FOR THE USER Human Albumin Biotest 20%, solution for infusion Human albumin Read this entire leaflet carefully before you start using this medicine, because it contains important

More information

Package leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin

Package leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin Package leaflet: Information for the user Cyanokit 5 g powder for solution for infusion hydroxocobalamin Read all of this leaflet carefully before using this medicine because it contains important information

More information

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin Package leaflet: Information for the patient IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

RATH & CO-TRADING PTY LTD Suite 3C, level 2, 58 Victor Crescent Narre Warren 3805

RATH & CO-TRADING PTY LTD Suite 3C, level 2, 58 Victor Crescent Narre Warren 3805 Specification Code(s) HS1069, HS1069-20, HS1074, Supersedes Page 1 of 5 Description: Fennugreek is derived from the seed of the annual herb known as, Trigonella Foenum-graecum, from the family N.O.Leguminosae.

More information

3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.

3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green. 1. NAME OF THE MEDICINAL PRODUCT Albutein 250 g/l, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Human albumin Albutein 250 g/l is a solution containing 250 g/l of total protein of

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 3 Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients Sodium Chloride Glucose Anhydrous

More information

Package Leaflet: Information for user

Package Leaflet: Information for user Package Leaflet: Information for user Hemosol B0 solution for haemodialysis/haemofiltration Sodium chloride/calcium chloride dihydrate/magnesium chloride hexahydrate/lactic acid/sodium hydrogen carbonate.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion PACKAGE LEAFLET: INFORMATION FOR THE USER Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion Cisatracurium Read all of this leaflet carefully before

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin.

SUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Flexbumin 200g/l solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Flexbumin 200 g/l is a solution containing 200 g/l

More information

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Sterile Potassium Chloride Concentrate 15%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 15% of Potassium Chloride in

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate PACKAGE LEAFLET: INFORMATION FOR THE USER Dopamine 40 mg/ml Sterile Concentrate Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.

More information

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS PRACTICE POINTS Give the right blood product to the right patient at the right time. Failure to correctly check the patient or the pack can be fatal. At the

More information

PLEASE READ Important Patient Safety Information Approved by HPRA

PLEASE READ Important Patient Safety Information Approved by HPRA PLEASE READ Important Patient Safety Information Approved by HPRA Valproate (Epilim ): NEW restrictions on use PREGNANCY PREVENTION PROGRAMME to be put in place. 16 April 2018 Dear Healthcare professional,

More information

Vamin 18 EF QUALITATIVE AND QUANTITATIVE COMPOSITION

Vamin 18 EF QUALITATIVE AND QUANTITATIVE COMPOSITION Title Page Information Dec. 2000 1 (7) Number Vamin 18 EF 121-01 1. NAME OF THE MEDICINAL PRODUCT Vamin 18 g N/l electrolyte-free infusion fluid, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1000

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Duraphat 5000 ppm Fluoride Toothpaste 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g of toothpaste contains 5 mg fluoride (as sodium fluoride),

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user ReFacto AF 250 IU powder and solvent for solution for injection ReFacto AF 500 IU powder and solvent for solution for injection ReFacto AF 1000 IU powder and solvent

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Menveo powder and solution for solution for injection Meningococcal Group A, C, W135 and Y conjugate vaccine Read all of this leaflet carefully before you or your

More information

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

Public Assessment Report for a Homeopathic Medicinal Product for Human Use IPAR Public Assessment Report for a Homeopathic Medicinal Product for Human Use Teetha Teething Gel HOA1149/007/001 HOA holder: A. Nelson & Company Limited Date: 16 November 2018 16 November 2018 CRN008K7Z

More information

HumaPen SAVVIO INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE

HumaPen SAVVIO INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE HumaPen SAVVIO INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For Single Patient Use Only www.lilly.ca INTRODUCTION HumaPen SAVVIO is designed for ease of use. You can give yourself multiple doses from one

More information

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

Read all of this leaflet carefully before you are given this medicine because it contains important information for you. [Aspen] Package Leaflet: Information for the Patient Ultiva for injection remifentanil hydrochloride Read all of this leaflet carefully before you are given this medicine because it contains important

More information

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges.

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. MS9662 MS9663 HumaPen LUXURA INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. Your HumaPen LUXURA

More information

CSL Behring. Beriplex P/N 250, 500 and 1000 IU Powder and solvent for solution for injection Human prothrombin complex

CSL Behring. Beriplex P/N 250, 500 and 1000 IU Powder and solvent for solution for injection Human prothrombin complex CSL Behring Package leaflet: Information for the user Beriplex P/N 250, 500 and 1000 IU Powder and solvent for solution for injection Human prothrombin complex Read all of this leaflet carefully before

More information

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE This guidance document contains Assured Advice under the ACS Primary Authority Scheme. For more details visit www.acs.org.uk/assured-advice STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE Laws regulating

More information

Public Assessment Report. Mebeverine hydrochloride 50mg/5ml Oral Suspension. (Mebeverine hydrochloride) UK Licence No: PL 44710/0024

Public Assessment Report. Mebeverine hydrochloride 50mg/5ml Oral Suspension. (Mebeverine hydrochloride) UK Licence No: PL 44710/0024 Public Assessment Report Mebeverine hydrochloride 50mg/5ml Oral Suspension (Mebeverine hydrochloride) UK Licence No: PL 44710/0024 Kinedexe UK Limited 1 LAY SUMMARY Mebeverine hydrochloride 50mg/5ml Oral

More information

Dorzolamide 20 mg/ml Eye Drops, Solution

Dorzolamide 20 mg/ml Eye Drops, Solution PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains

More information

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate Package leaflet: Information for the user 100 mg/ml concentrate for solution for infusion argatroban monohydrate Read all of this leaflet carefully before you start using this medicine because it contains

More information

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges.

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. MS9673 HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. The colour of your HumaPen

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection PACKAGE LEAFLET: INFORMATION FOR THE USER Calcium Folinate 10 mg/ml Injection Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.

More information

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate Package leaflet: Information for the user Exembol 1 mg/ml solution for infusion argatroban monohydrate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone Package leaflet: information for the user OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone Read all of this leaflet carefully before you are given this medicine because it contains

More information

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion idursulfase This medicine is subject to additional monitoring. This will allow quick identification of new

More information

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE Laws regulating the sale of tobacco products across the UK are changing. This guidance outlines how retailers must comply with the new regulations.

More information

Package leaflet: Information for the user. Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion topotecan

Package leaflet: Information for the user. Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion topotecan Package leaflet: Information for the user Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion topotecan Read all of this leaflet carefully before you start using this medicine because it

More information

Instructions for Use. Wright Medical Technology 1023 Cherry Road Memphis, TN USA

Instructions for Use. Wright Medical Technology 1023 Cherry Road Memphis, TN USA Instructions for Use Wright Medical Technology 1023 Cherry Road Memphis, TN 38117 USA 1-800-238-7117 Processed from Donated Human Tissue for Wright Medical Technology by LifeCell Corporation One Millennium

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully. It provides a summary of information about your medicine.

More information

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception Pharmaceutical Society of Ireland Version 4 December 2016 Updates made following

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Cisatracurium 2 mg/ml Solution for injection/ infusion Cisatracurium 5 mg/ml Solution for injection/ infusion Cisatracurium The name of your medicine are Cisatracurium

More information

Package leaflet: Information for the patient. Xofigo 1100 kbq/ml solution for injection radium Ra 223 dichloride

Package leaflet: Information for the patient. Xofigo 1100 kbq/ml solution for injection radium Ra 223 dichloride Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end

More information

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac Package leaflet: Information for the user NEVANAC 1 mg/ml eye drops, suspension Nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

The Yellow Card scheme why are GPs under-reporting?

The Yellow Card scheme why are GPs under-reporting? The Yellow Card scheme why are GPs under-reporting? Steve Chaplin MSc, MRPharmS Total number of reports 18000 16000 14000 12000 10000 8000 6000 The effectiveness of the Yellow Card scheme has been limited

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user ReFacto AF 250 IU powder and solvent for solution for injection in pre-filled syringe ReFacto AF 500 IU powder and solvent for solution for injection in pre-filled

More information

Account Application Form

Account Application Form Dear Customer, Thank you for your recent enquiry regarding opening an account with NHS Supply Chain. NHS Supply Chain provides customer-focused healthcare products and supply chain services to the UK s

More information

PRESCRIBING INFORMATION

PRESCRIBING INFORMATION PRESCRIBING INFORMATION Potassium Chloride in Lactated Ringer s Injection, USP Sodium chloride 6.0 g/l, Sodium lactate 3.1 g/l, Potassium chloride 1.8 g/l and Calcium chloride 0.2 g/l Sterile solution

More information

COMPOUND SODIUM LACTATE (HARTMANN S SOLUTION) AND 5% GLUCOSE

COMPOUND SODIUM LACTATE (HARTMANN S SOLUTION) AND 5% GLUCOSE COMPOUND SODIUM LACTATE (HARTMANN S SOLUTION) AND 5% GLUCOSE Compound Sodium Lactate (Hartmann s solution) and 5% Glucose intravenous, infusion solution Composition The ingredients in Compound Sodium Lactate

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Nutrineal PD4 with 1.1% amino acids. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION L-Tyrosine 0.300 g/l L-Tryptophan 0.270 g/l L-Phenylalanine

More information

Package leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin

Package leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin Package leaflet: Information for the user Tobramycin 40 mg/ml Solution for Injection tobramycin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 1 (9 mg/ml) solution for injection/infusion (UK/IE) Natriumklorid Animalcare 9 mg/ml solution for injection/infusion

More information

Package leaflet: Information for the user

Package leaflet: Information for the user CSL Behring Package leaflet: Information for the user Alburex 5, 50 g/l, solution for infusion & Alburex 20, 200 g/l, solution for infusion Human albumin Read all of this leaflet carefully before you are

More information